011503 Dapsone 6% / Niacinamide 2% / Spironolactone 5%
Product Images NDC 72934-1211

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for 011503 Dapsone 6% / Niacinamide 2% / Spironolactone 5% (NDC 72934-1211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

W (2 End)

Sincerus Florida, LLC is a company based in Pompano Beach, FL that can be contacted at (800) 604-5032. This company may be contacted to report suspected adverse reactions, and information can also be obtained through the FDA's website or by contacting the FDA at (800) FDA-1088. The LS-01-00000-00 is for office use only and is not intended for resale.*

FDA Label Image

D (1211 2 Front)

FDA Label Image

S (1211 2 Middle)

This text appears to be a list of ingredients and their corresponding percentages in a product. The product contains Butylated Hydroxytoluene NF BHT at 0.1%, EAVERARHBIN at 0.25%, and PropyleneGlcolUSP at 5%. The purpose or type of product is not clear from this text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.